MASSDEVICE ON CALL — Opponents of the 2.3% medical device tax are looking for opportunities to address their concerns during the Congressional debates of the so-called "fiscal cliff."
The discussions may be gaining momentum as more voices in the House and Senate call for either repeal or delay in implementation for the tax, which takes effect January 1.
Certain groups are voicing more private concerns, such as stakeholders of the dental devices industry, which have argued for a narrow exemption for devices that aren’t covered by the Affordable Care Act, which the medical device tax is intended to help support.
"The excise tax was created to help pay for the implementation of health-care reform, but dentistry is not covered by insurance," National Assn. of Dental Laboratories executive director Bennet Napier told Dentistry IQ. "So we argued that dentistry should be exempt, because there’s no benefit to dentistry from this tax."
Other groups are calling for a delay in implementation of the tax, given that the IRS released its final guidelines on the levy just last week.
A group of 18 Senators yesterday submitted a letter to Senate Majority Leader Harry Reid (D-Nev.), asking him to delay implementation of the 2.3% medical device tax in hopes of pushing the levy past its January 1 start date.
AT&T goes solo on asthma warning sensor
Technology giant AT&T developed its own asthma sensor that detects particles in the air and warns patients of a potential trigger for an asthma attack.
Ultrasound beats stethoscopes for point-of-care pneumonia detection
Point-of-care ultrasound beats traditional stethoscope methods when it comes to detecting and diagnosing pneumonia in children and young adults, according to researchers at the Mount Sinai Hospital School of Medicine.
Stryker passes Intuitive Surgical in market cap
Orthopedic giant Stryker (NYSE:SYK) surpassed robot-assisted surgical devices maker Intuitive Surgical (NSDQ:ISRG) in market cap, surpassing Intuitive to become the 143rd largest company on the S&P 500.
Medtech CEOs talk about rehabilitating veterans
Medical device CEOs Michael Minogue of Abiomed (NSDQ:ABMD) and Brian Concannon of Haemonetics (NYSE:HAE) teamed up to tell NECN TV about the Medtech Veterans program, which was 1st unveiled at MassDevice.com’s Big 100 East in July.